WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

THE COMPOUND IN BOESENBERGIA PANDURATA RHIZOME AS HIV-1 PROTEASE INHIBITOR: IN-SILICO STUDY

Resmi Mustarichie*, Sandra Megantara and Ike Susanti

ABSTRACT

HIV is a major source of public health problems globally and has claimed an estimated 33 million people. There are more than 20 compounds of the terpenes and sterols that are useful as anti-HIV agents that can be studied to see if they are bound to the HIV-1 receptor compounds. In this article, we report in-silio study of the compounds of Boesenbergia pandurata as HIV-1 Protease inhibitor and result is that 4-Hydroxypanduratin and panduratin A as a good candidate for HIV-1 treatment by using autodock and pre-ADMET method.

Keywords: In-silico, Boesenbergia pandurate, HIV-1, Protease inhibitor, ADMET


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More